Trihexyphenidyl
Back to searchMolecule Structure
Scientific Name
Trihexyphenidyl
Description of the Drug
Trihexyphenidyl is an antispasmodic drug used as an adjunct drug in the management of parkinsonism and as a treatment for extrapyramidal symptoms caused by drugs affecting the central nervous system (CNS).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00376
http://www.drugbank.ca/drugs/DB00376
Brand Name(s)
Not Available
Company Owner(s)
Lederle Laboratories Div American Cyanamid Co, Schering Corp Sub Schering Plough Corp, Pharmaceutical Associates Inc, Watson Laboratories Inc, Mikart Llc, Natco Pharma Ltd, Vangard Laboratories Inc Div Midway Medical Co, Pharmaceutical Ventures Ltd, Nylos Trading Co Inc, Novitium Pharma Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Muscarinic acetylcholine receptor M1 | SINGLE PROTEIN | ANTAGONIST | CHEMBL216 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34645 | |
PharmGKB | PA164747026 | |
Human Metabolome Database | HMDB0014520 | |
DrugBank | DB00376 | |
PubChem: Thomson Pharma | 14751778 | |
PubChem | 5572 | |
Mcule | MCULE-6065307656 | |
LINCS | LSM-5060 | |
Nikkaji | J5.826B | J19.358E |
BindingDB | 81462 | |
EPA CompTox Dashboard | DTXSID4023705 | |
DrugCentral | 2745 | |
ChemicalBook | CB9234619 | |
Guide to Pharmacology | 7315 | |
rxnorm | TRIHEXYPHENIDYL HYDROCHLORIDE | TRIHEXYPHENIDYL |
KEGG Ligand | C07171 | |
ChEBI | 9720 |